Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.

Rossetti B, Gagliardini R, Meini G, Sterrantino G, Colangeli V, Re MC, Latini A, Colafigli M, Vignale F, Rusconi S, Micheli V, Di Biagio A, Orofino G, Ghisetti V, Fantauzzi A, Vullo V, Grima P, Francisci D, Mastroianni C, Antinori A, Trezzi M, Lisi L, Navarra P, Canovari B, D'Arminio Monforte A, Lamonica S, D'Avino A, Zazzi M, Di Giambenedetto S, De Luca A; for GUSTA trial study group.

PLoS One. 2017 Nov 21;12(11):e0187393. doi: 10.1371/journal.pone.0187393. eCollection 2017.

2.

Clinical Improvement of Subacute and Chronic Otitis Media With Effusion Treated With Hyaluronic Acid Plus Hypertonic Solution via Nasal Lavage: A Randomized Controlled Trial.

Cioffi L, Gallo P, D'Avino A, Carlomagno F, Aloi G, D'Onofrio A, Del Gaizo D, Giuliano M, De Franchis R, Sandomenico ML, Pecoraro A.

Glob Pediatr Health. 2017 Sep 1;4:2333794X17725983. doi: 10.1177/2333794X17725983. eCollection 2017.

3.

3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir.

Gagliardini R, Bandera A, Zaccarelli M, Sterrantino G, Latini A, D'Avino A, Lapadula G, Antinori A, Cauda R, De Luca A, Gori A, Di Giambenedetto S, Fabbiani M.

Antivir Ther. 2017 Aug 11. doi: 10.3851/IMP3188. [Epub ahead of print]

PMID:
28799920
4.

i-motif structures in long cytosine-rich sequences found upstream of the promoter region of the SMARCA4 gene.

Benabou S, Aviñó A, Lyonnais S, González C, Eritja R, De Juan A, Gargallo R.

Biochimie. 2017 Sep;140:20-33. doi: 10.1016/j.biochi.2017.06.005. Epub 2017 Jun 12.

PMID:
28619677
5.

Stabilization of Telomeric I-Motif Structures by (2'S)-2'-Deoxy-2'-C-Methylcytidine Residues.

Aviñó A, Dellafiore M, Gargallo R, González C, Iribarren AM, Montserrat J, Eritja R.

Chembiochem. 2017 Jun 19;18(12):1123-1128. doi: 10.1002/cbic.201700112. Epub 2017 May 15.

PMID:
28407336
6.

Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients.

Gagliardini R, Fabbiani M, Colafigli M, D'Avino A, Mondi A, Borghetti A, Lamonica S, Cauda R, De Luca A, Di Giambenedetto S.

J Chemother. 2017 Oct;29(5):299-307. doi: 10.1080/1120009X.2016.1269040. Epub 2016 Dec 26.

PMID:
28019192
7.

The effect of l-thymidine, acyclic thymine and 8-bromoguanine on the stability of model G-quadruplex structures.

Aviñó A, Mazzini S, Fàbrega C, Peñalver P, Gargallo R, Morales JC, Eritja R.

Biochim Biophys Acta. 2017 May;1861(5 Pt B):1205-1212. doi: 10.1016/j.bbagen.2016.09.030. Epub 2016 Oct 2.

8.

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.

Raffetti E, Postorino MC, Castelli F, Casari S, Castelnuovo F, Maggiolo F, Di Filippo E, D'Avino A, Gori A, Ladisa N, Di Pietro M, Sighinolfi L, Zacchi F, Torti C.

BMC Public Health. 2016 Aug 25;16(1):878. doi: 10.1186/s12889-016-3477-z.

9.

Controlling the Reversible Assembly of Liposomes through a Multistimuli Responsive Anchored DNA.

Hernández-Ainsa S, Ricci M, Hilton L, Aviñó A, Eritja R, Keyser UF.

Nano Lett. 2016 Jul 13;16(7):4462-6. doi: 10.1021/acs.nanolett.6b01618. Epub 2016 Jul 1.

10.

Glucose-Nucleobase Pseudo Base Pairs: Biomolecular Interactions within DNA.

Vengut-Climent E, Gómez-Pinto I, Lucas R, Peñalver P, Aviñó A, Fonseca Guerra C, Bickelhaupt FM, Eritja R, González C, Morales JC.

Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8643-7. doi: 10.1002/anie.201603510. Epub 2016 Jun 22.

PMID:
27328804
11.

Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE).

Milanini B, Ciccarelli N, Fabbiani M, Baldonero E, Limiti S, Gagliardini R, Borghetti A, D'Avino A, Mondi A, Colafigli M, Cauda R, Di Giambenedetto S.

Clin Neuropsychol. 2016 Jan-Dec;30(sup1):1457-1468. Epub 2016 May 16.

PMID:
27180611
12.

Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy.

Borghetti A, Baldin G, Ciccullo A, Gagliardini R, D'Avino A, Mondi A, Ciccarelli N, Lamonica S, Fanti I, Trecarichi E, Fabbiani M, Cauda R, De Luca A, Di Giambenedetto S.

J Antimicrob Chemother. 2016 Aug;71(8):2359-61. doi: 10.1093/jac/dkw147. Epub 2016 May 4. No abstract available.

PMID:
27147306
13.

A New Radiographic Classification for Distal Shaft Fifth Metatarsal Fractures.

Soave RL, Bleazey S, Rudowsky A, Clarke RV, Avino A Jr, Kuchar DJ.

J Foot Ankle Surg. 2016 Jul-Aug;55(4):803-7. doi: 10.1053/j.jfas.2016.03.001. Epub 2016 Apr 12.

PMID:
27079304
14.

The Effect of Small Cosolutes that Mimic Molecular Crowding Conditions on the Stability of Triplexes Involving Duplex DNA.

Aviñó A, Mazzini S, Gargallo R, Eritja R.

Int J Mol Sci. 2016 Feb 5;17(2):211. doi: 10.3390/ijms17020211.

15.

Sensitive and label-free detection of miRNA-145 by triplex formation.

Aviñó A, Huertas CS, Lechuga LM, Eritja R.

Anal Bioanal Chem. 2016 Jan;408(3):885-93. doi: 10.1007/s00216-015-9180-6. Epub 2015 Nov 24.

PMID:
26603177
16.

Gold-Coated Superparamagnetic Nanoparticles for Single Methyl Discrimination in DNA Aptamers.

Tintoré M, Mazzini S, Polito L, Marelli M, Latorre A, Somoza Á, Aviñó A, Fàbrega C, Eritja R.

Int J Mol Sci. 2015 Nov 18;16(11):27625-39. doi: 10.3390/ijms161126046.

17.

Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study.

Mondi A, Fabbiani M, Ciccarelli N, Colafigli M, D'Avino A, Borghetti A, Gagliardini R, Cauda R, De Luca A, Di Giambenedetto S.

J Antimicrob Chemother. 2015;70(6):1843-9. doi: 10.1093/jac/dkv037. Epub 2015 Feb 26.

PMID:
25885326
18.

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre.

Borghetti A, Mondi A, Piccoli B, Gagliardini R, Lamonica S, Ciccarelli N, D'Avino A, Pallavicini F, Cauda R, De Luca A, Fabbiani M, Di Giambenedetto S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19817. doi: 10.7448/IAS.17.4.19817. eCollection 2014.

19.

Liver fibrosis is associated with cognitive impairment in HIV-positive patients.

Ciccarelli N, Fabbiani M, Grima P, Limiti S, Fanti I, Mondi A, Gagliardini R, D'Avino A, Borghetti A, Cauda R, Di Giambenedetto S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19722. doi: 10.7448/IAS.17.4.19722. eCollection 2014.

20.

Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk.

D'Avino A, Lassandro A, Lamonica S, Piccoli B, Fabbiani M, Mondi A, Gagliardini R, Borghetti A, Fanti I, Pallavicini F, Cauda R, Di Giambenedetto S.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19570. doi: 10.7448/IAS.17.4.19570. eCollection 2014.

Supplemental Content

Loading ...
Support Center